First human test: scientists check safety of new drug in healthy women
NCT ID NCT06467201
Summary
This was a first-in-human study to check the basic safety of a new drug called AMN1126 and see how the body processes it. It involved 18 healthy postmenopausal women who received a single, increasing dose of the drug. The main goal was to monitor for any side effects and measure the drug's levels in the blood over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY POSTMENOPAUSAL WOMEN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Pharma CR
Miami, Florida, 33147, United States
-
Health1 Superspeciality Hospital
Ahmedabad, Gujarat, 380058, India
Conditions
Explore the condition pages connected to this study.